ID

29016

Description

Study part: Serious Adverse Event Reporting. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.

Keywords

  1. 2/20/18 2/20/18 -
Copyright Holder

Roche

Uploaded on

February 20, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Serious Adverse Event Reporting rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g

Serious Adverse Event Reporting

SERIOUS ADVERSE EVENT REPORTING
Description

SERIOUS ADVERSE EVENT REPORTING

Alias
UMLS CUI-1
C1519255
Subject Number:
Description

Subject Number

Data type

text

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Description

Subject Initials

Data type

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Visit Date:
Description

Visit Date

Data type

date

Alias
UMLS CUI [1]
C1320303
PRIMARY SERIOUS ADVERSE EVENT
Description

Adverse event

Data type

text

Alias
UMLS CUI [1]
C0877248
Ocular AEs Only Indicate Eye Affected
Description

eye

Data type

text

Alias
UMLS CUI [1]
C0015392
ONSET
Description

Onset

Data type

date

Alias
UMLS CUI [1]
C0574845
RESOLUTION
Description

end date

Data type

date

Alias
UMLS CUI [1]
C0806020
Check if event is ongoing
Description

adverse event ongoing

Data type

boolean

Alias
UMLS CUI [1]
C2826663
SAE INTENSITY
Description

Adverse Event intensity

Data type

integer

Alias
UMLS CUI [1]
C1710066
SAE SUSPECTED TO BE CAUSED BY STUDY DRUG?
Description

cause of adverse event

Data type

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0877248
OTHER SUSPECTED CAUSES OF SAE
Description

cause of adverse event

Data type

integer

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0877248
ACTION TAKEN WITH STUDY DRUG DUE TO AE
Description

Action taken

Data type

integer

Alias
UMLS CUI [1]
C2826626
TREATMENT FOR AE
Description

adverse event therapy

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was the subject hospitalized due to serious AE?
Description

Hospitalization

Data type

boolean

Alias
UMLS CUI [1]
C0019993
If Yes, Admission Date:
Description

Admission date

Data type

date

Alias
UMLS CUI [1]
C1302393
The primary Adverse Event was considered serious because
Description

reason

Data type

integer

Alias
UMLS CUI [1]
C0566251
Date of Death:
Description

Date of Death

Data type

date

Alias
UMLS CUI [1]
C1148348
Autopsy performed?
Description

Autopsy

Data type

text

Alias
UMLS CUI [1]
C0004398
Relevant Diagnostic Tests Performed (To diagnose or confirm primary SAE):
Description

Relevant Diagnostic Tests Performed (To diagnose or confirm primary SAE):

Alias
UMLS CUI-1
C0086143
Relevant Diagnostic Tests performed?
Description

Diagnostic tests

Data type

boolean

Alias
UMLS CUI [1]
C0086143
Relevant Diagnostic Test
Description

Diagnostic tests

Data type

text

Alias
UMLS CUI [1]
C0086143
Date Performed
Description

Date Performed

Data type

date

Alias
UMLS CUI [1,1]
C0430022
UMLS CUI [1,2]
C0011008
Relevant Diagnostic Test Result
Description

test result

Data type

text

Alias
UMLS CUI [1]
C0456984
Result Pending
Description

test result

Data type

boolean

Alias
UMLS CUI [1]
C0456984
Additional Case Details:
Description

• Associated signs and symptoms, if applicable • Clinical course (e.g. sequence of events) • Elaborate on suspected causes of SAE • Any specific treatment for the SAE

Data type

text

Alias
UMLS CUI [1]
C1546922

Similar models

Serious Adverse Event Reporting

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
SERIOUS ADVERSE EVENT REPORTING
C1519255 (UMLS CUI-1)
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Adverse event
Item
PRIMARY SERIOUS ADVERSE EVENT
text
C0877248 (UMLS CUI [1])
Item
Ocular AEs Only Indicate Eye Affected
text
C0015392 (UMLS CUI [1])
Code List
Ocular AEs Only Indicate Eye Affected
CL Item
Right (Right)
C0229089 (UMLS CUI-1)
(Comment:en)
CL Item
Left (Left)
C0229090 (UMLS CUI-1)
(Comment:en)
Onset
Item
ONSET
date
C0574845 (UMLS CUI [1])
end date
Item
RESOLUTION
date
C0806020 (UMLS CUI [1])
adverse event ongoing
Item
Check if event is ongoing
boolean
C2826663 (UMLS CUI [1])
Item
SAE INTENSITY
integer
C1710066 (UMLS CUI [1])
Code List
SAE INTENSITY
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
cause of adverse event
Item
SAE SUSPECTED TO BE CAUSED BY STUDY DRUG?
boolean
C0015127 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item
OTHER SUSPECTED CAUSES OF SAE
integer
C0015127 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Code List
OTHER SUSPECTED CAUSES OF SAE
CL Item
None  (1)
C0549184 (UMLS CUI-1)
(Comment:en)
CL Item
Disease Under Study (2)
C0012634 (UMLS CUI-1)
(Comment:en)
CL Item
Withdrawal of Study Drug (3)
C2349954 (UMLS CUI-1)
C0304229 (UMLS CUI-2)
(Comment:en)
CL Item
Concurrent Illness (4)
C0009488 (UMLS CUI-1)
(Comment:en)
CL Item
Concurrent Medication (5)
C2347852 (UMLS CUI-1)
(Comment:en)
CL Item
Non-Drug Intervention (6)
C3661844 (UMLS CUI-1)
(Comment:en)
CL Item
Treatment Procedure (7)
C0087111 (UMLS CUI-1)
(Comment:en)
Item
ACTION TAKEN WITH STUDY DRUG DUE TO AE
integer
C2826626 (UMLS CUI [1])
Code List
ACTION TAKEN WITH STUDY DRUG DUE TO AE
CL Item
None (1)
CL Item
Drug permanently discontinued (2)
CL Item
Dose held (3)
CL Item
Not applicable (4)
Item
TREATMENT FOR AE
integer
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Code List
TREATMENT FOR AE
CL Item
None (1)
CL Item
Medication (2)
CL Item
Procedure/ Surgery (3)
CL Item
Subject DC from study (4)
Hospitalization
Item
Was the subject hospitalized due to serious AE?
boolean
C0019993 (UMLS CUI [1])
Admission date
Item
If Yes, Admission Date:
date
C1302393 (UMLS CUI [1])
Item
The primary Adverse Event was considered serious because
integer
C0566251 (UMLS CUI [1])
Code List
The primary Adverse Event was considered serious because
CL Item
It resulted in death (1)
C1306577 (UMLS CUI-1)
(Comment:en)
CL Item
It was life-threatening (i.e., the recorded AE placed subject at immediate risk of death) (2)
C2826244 (UMLS CUI-1)
(Comment:en)
CL Item
It required or prolonged inpatient hospitalization (i.e., the recorded AE caused the subject to behospitalized or prolonged hospitalization beyond the expected length of stay) (3)
C0019993 (UMLS CUI-1)
(Comment:en)
CL Item
It was disabling (i.e., the recorded AE resulted in substantial disruption of the subject’s ability to carry out normal life functions) (4)
C4061999 (UMLS CUI-1)
(Comment:en)
CL Item
It is a congenital anomaly/birth defect in offspring of study subject (5)
C0000768 (UMLS CUI-1)
(Comment:en)
CL Item
It does not meet any of the above serious criteria, but may jeopardize the subject, and may require medical or surgical intervention to prevent one of the outcomes listed above. (6)
C0184661 (UMLS CUI-1)
(Comment:en)
Date of Death
Item
Date of Death:
date
C1148348 (UMLS CUI [1])
Item
Autopsy performed?
text
C0004398 (UMLS CUI [1])
Code List
Autopsy performed?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
Unknown (Unknown)
Item Group
Relevant Diagnostic Tests Performed (To diagnose or confirm primary SAE):
C0086143 (UMLS CUI-1)
Diagnostic tests
Item
Relevant Diagnostic Tests performed?
boolean
C0086143 (UMLS CUI [1])
Diagnostic tests
Item
Relevant Diagnostic Test
text
C0086143 (UMLS CUI [1])
Date Performed
Item
Date Performed
date
C0430022 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
test result
Item
Relevant Diagnostic Test Result
text
C0456984 (UMLS CUI [1])
test result
Item
Result Pending
boolean
C0456984 (UMLS CUI [1])
additional information
Item
Additional Case Details:
text
C1546922 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial